REGULATED PRESS RELEASE published on 04/27/2026 at 17:35, 11 days 17 hours ago Disclosure of transactions in own shares from April 20 to April 24, 2026
REGULATED PRESS RELEASE published on 04/27/2026 at 17:35, 11 days 17 hours ago Déclaration hebdomadaire d'opérations effectuées du 20 au 24 avril 2026
BRIEF published on 04/23/2026 at 14:35, 15 days 20 hours ago Kurma Partners lève 215 millions d'euros pour Biofund IV Investissement Biotechnologie EURAZEO Kurma Partners Biofund IV
BRIEF published on 04/23/2026 at 14:35, 15 days 20 hours ago EURAZEO'S KURMA PARTNERS SECURES €215 MILLION FOR BIOFUND IV Biotechnology Investments Venture Capital Kurma Partners Biofund IV
REGULATED PRESS RELEASE published on 04/23/2026 at 14:30, 15 days 20 hours ago KURMA PARTNERS, MEMBRE DU GROUPE EURAZEO, ANNONCE LE CLOSING FINAL DE SON NOUVEAU FONDS BIOFUND IV A 215 MILLIONS D’EUROS Kurma Partners, membre du groupe Eurazeo, annonce la clôture finale de son nouveau fonds Biofund IV à 215 millions d'euros, renforçant son implication dans les biotechs disruptives en Europe Investissement EURAZEO Kurma Partners Biofund IV Biotechs
REGULATED PRESS RELEASE published on 04/23/2026 at 14:30, 15 days 20 hours ago KURMA PARTNERS, AN EURAZEO GROUP COMPANY, CLOSES €215 MILLION BIOFUND IV Kurma Partners, a Eurazeo group company, closes €215 million Biofund IV, supporting disruptive therapeutic solutions for severe diseases. Total AUM now at €1 billion EURAZEO AUM Kurma Partners Biofund IV Therapeutic Solutions
REGULATED PRESS RELEASE published on 04/20/2026 at 17:35, 18 days 17 hours ago Disclosure of transactions in own shares from April 13 to April 17, 2026
REGULATED PRESS RELEASE published on 04/20/2026 at 17:35, 18 days 17 hours ago Déclaration hebdomadaire d'opérations effectuées du 13 au 17 avril 2026
REGULATED PRESS RELEASE published on 04/13/2026 at 17:35, 25 days 17 hours ago Déclaration hebdomadaire d'opérations effectuées du 1er au 10 avril 2026
REGULATED PRESS RELEASE published on 04/13/2026 at 17:35, 25 days 17 hours ago Disclosure of transactions in own shares from April 1 to April 10, 2026
Published on 05/09/2026 at 01:30, 9 hours 21 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 10 hours 51 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 14 hours 12 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 15 hours 38 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 15 hours 48 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 15 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 15 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 15 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 15 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 15 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL